Guinness Asset Management LTD reduced its stake in shares of Addus HomeCare Co. (NASDAQ:ADUS – Free Report) by 3.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 4,495 shares of the company’s stock after selling 168 shares during the period. Guinness Asset Management LTD’s holdings in Addus HomeCare were worth $564,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. American Century Companies Inc. raised its stake in shares of Addus HomeCare by 90.6% in the 2nd quarter. American Century Companies Inc. now owns 18,393 shares of the company’s stock valued at $2,136,000 after acquiring an additional 8,743 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in Addus HomeCare by 0.8% during the second quarter. Dimensional Fund Advisors LP now owns 714,253 shares of the company’s stock worth $82,930,000 after purchasing an additional 5,421 shares during the period. Amalgamated Bank grew its holdings in Addus HomeCare by 8.4% during the second quarter. Amalgamated Bank now owns 5,330 shares of the company’s stock valued at $619,000 after purchasing an additional 412 shares during the last quarter. Intech Investment Management LLC bought a new position in shares of Addus HomeCare in the second quarter valued at approximately $245,000. Finally, Sei Investments Co. lifted its stake in shares of Addus HomeCare by 22.2% in the second quarter. Sei Investments Co. now owns 13,770 shares of the company’s stock worth $1,599,000 after buying an additional 2,499 shares during the last quarter. Institutional investors and hedge funds own 95.35% of the company’s stock.
Insider Transactions at Addus HomeCare
In related news, EVP Roberton James Stevenson sold 2,250 shares of Addus HomeCare stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the completion of the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. This trade represents a 18.05 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO R Dirk Allison sold 12,500 shares of the business’s stock in a transaction that occurred on Monday, November 25th. The stock was sold at an average price of $123.16, for a total transaction of $1,539,500.00. Following the sale, the chief executive officer now directly owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 39,750 shares of company stock valued at $4,930,750 in the last three months. 4.60% of the stock is owned by corporate insiders.
Addus HomeCare Trading Up 0.4 %
Addus HomeCare (NASDAQ:ADUS – Get Free Report) last announced its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.02. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The firm had revenue of $289.80 million during the quarter, compared to analysts’ expectations of $289.42 million. During the same quarter last year, the company earned $1.03 earnings per share. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. Equities analysts forecast that Addus HomeCare Co. will post 4.58 earnings per share for the current fiscal year.
Analyst Ratings Changes
A number of research firms recently issued reports on ADUS. StockNews.com lowered shares of Addus HomeCare from a “buy” rating to a “hold” rating in a research note on Thursday. KeyCorp initiated coverage on Addus HomeCare in a research report on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. JMP Securities started coverage on Addus HomeCare in a research report on Monday, December 16th. They set an “outperform” rating and a $150.00 price objective for the company. Oppenheimer raised their target price on Addus HomeCare from $140.00 to $145.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Finally, Royal Bank of Canada reiterated an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a report on Thursday, November 14th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, Addus HomeCare has an average rating of “Moderate Buy” and a consensus price target of $133.67.
Read Our Latest Report on ADUS
Addus HomeCare Company Profile
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
- Five stocks we like better than Addus HomeCare
- Top Biotech Stocks: Exploring Innovation Opportunities
- AMD: Loop Capital’s Buy Rating Reinforces Investor Confidence
- How to Choose Top Rated Stocks
- Momentum Is Building for Qualcomm to Have a Strong Run in 2025
- 3 Warren Buffett Stocks to Buy Now
- There May Still Be Time to Get in on These 3 Trending Biotechs
Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.